The UK Health Security Agency (UKHSA) has released a new tool that will help research and development efforts of diagnostics, vaccines, and treatments for pathogens that pose the greatest risk to public health.
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.
The National Academy of Sciences (PNAS) has published new research which reveals that Huntington's Disease may take affect in people much earlier on in life than originally expected and that a new drug may be paramount in controlling the disease.
Ken Arnold, Creative Director at Wellcome explains what contagious cities are and the extent to which they are considered to be cultural programming in a policy context
Public Health England is urging students to get MenACWY and MMR vaccines before the start of the new college or university year to ensure they're protected against deadly diseases
New data published by Public Health England (PHE) show that deaths from hepatitis C-related end-stage liver disease have fallen by 11% in 2017 compared to the previous year
The work of Vytenis Andriukaitis, European Commissioner for Health & Food Safety, with responsibility for modernising health policy, building up knowledge and tackling preventable diseases
Professor John Wilding from the University of Liverpool charts priorities for improving patient care in the UK when it comes to the prevalent condition, Type 2 diabetes
Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explains why air matters, for everybody, everywhere (H2)
Helen McShane, Professor of Vaccinology at The Jenner Institute, University of Oxford reveals the current status of tuberculosis vaccine development in the world today.
Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today
Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
Today, The Aplastic Anaemia Trust (AAT) launches their new research strategy, inviting prospective applicants to come forward with proposals for truly translational research into aplastic anaemia (AA), as CEO Grazina Berry reveals
Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
